hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.
New Chinese biotech Funnel has signed a $2bn-plus partnership with Third Rock Ventures, focused on using its AI platform to discover novel biologics.
Amazon Web Services has committed $100m in AI and cloud technology capacity to support the building of health services for "underserved communities."
The issue isn't whether synthetic data is useful. It is what question we are asking it to answer.
UK start-up Potential Sciences emerged from stealth today with a sizeable seed funding round and an ambition to transform drug discovery with AI.
Editor's Picks
